The CenterWatch Monthly, October 2011

Tuesday, October 4, 2011 11:01 AM

Sponsors take action to reduce protocol amendments

Protocol amendments commonly have been considered an inconvenient—but inevitable—part of drug development. A recent Tufts CSDD study found each amended protocol has an average of 2.3 amendments, resulting in four months of additional time to implement. On average, the study found it cost nearly a half-million dollars to implement a single protocol amendment. It indicated a large proportion of them could be prevented. Now, a few leading biopharmaceutical companies have launched efforts to reduce and prevent certain amendments through better protocol designs and...

 

EHR integration could change the game for clinical research

A few short years ago clinical research sites struggled with moving their paper systems to electronic form. The automation added efficiencies, but information often had to be re-entered into different systems, adding errors and taking time from patient care. Now, a different kind of electronic integration is poised to redefine how sites conduct research studies and gather data. Proponents say the electronic health record can eliminate duplication of data, reduce the overwhelming administrative costs and create...

 

Eye On Isis Pharmaceuticals

Isis Pharmaceuticals focuses on antisense drug development, applicable to many different disease targets. Its strategy includes licensing its drugs to partners before late-phase development and marketing. This allows Isis to direct its capital to discovery and early development rather than commercialization and sales, while still benefiting from licensing fees, equity purchase payments, milestone payments and R&D funding. To protect its status as an innovator in RNA-based drug discovery and development, Isis has implemented a patent strategy...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

 

Share:          
CWWeekly

May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs